Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 52(2011), 2 vom: 01. Feb., Seite 335-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Burbury, Kate [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.05.2011 Date Revised 16.01.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3109/10428194.2010.534210 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM205486371 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM205486371 | ||
| 003 | DE-627 | ||
| 005 | 20231223234037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/10428194.2010.534210 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0685.xml |
| 035 | |a (DE-627)NLM205486371 | ||
| 035 | |a (NLM)21281241 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Burbury, Kate |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.05.2011 | ||
| 500 | |a Date Revised 16.01.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Benzamides |2 NLM | |
| 650 | 7 | |a Oncogene Proteins, Fusion |2 NLM | |
| 650 | 7 | |a Piperazines |2 NLM | |
| 650 | 7 | |a Pyrimidines |2 NLM | |
| 650 | 7 | |a mRNA Cleavage and Polyadenylation Factors |2 NLM | |
| 650 | 7 | |a Imatinib Mesylate |2 NLM | |
| 650 | 7 | |a 8A1O1M485B |2 NLM | |
| 650 | 7 | |a FIP1L1-PDGFRA fusion protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 650 | 7 | |a Receptor, Platelet-Derived Growth Factor alpha |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Chew, Lee Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Westerman, David |e verfasserin |4 aut | |
| 700 | 1 | |a Catalano, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Seymour, John F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 52(2011), 2 vom: 01. Feb., Seite 335-8 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2011 |g number:2 |g day:01 |g month:02 |g pages:335-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3109/10428194.2010.534210 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2011 |e 2 |b 01 |c 02 |h 335-8 | ||